Amritaa Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 11-01-2025
- Paid Up Capital ₹ 1.00 Cr
as on 11-01-2025
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.02 Cr
as on 11-01-2025
About Amritaa Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹1.02 Cr.
Pradeep Mupparaju, Chirumamilla Rakesh, Suguna Reddy, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110AP2021PTC117400
- Company No.
117400
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Amritaa Diagnostics?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Mupparaju  | Director | 17-Feb-2021 | Current |
| Chirumamilla Rakesh | Director | 17-Feb-2021 | Current |
| Suguna Reddy | Director | 10-Mar-2021 | Current |
| Sai Busireddy | Director | 10-Mar-2021 | Current |
| Ravi Golla | Director | 31-Jul-2021 | Current |
| Apuroopa Murari | Director | 12-Oct-2022 | Current |
Financial Performance of Amritaa Diagnostics.
Amritaa Diagnostics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Amritaa Diagnostics?
Unlock access to Amritaa Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Sep 2022 | ₹0.71 M | Open |
State Bank Of India Creation Date: 18 Aug 2021 | ₹9.50 M | Open |
How Many Employees Work at Amritaa Diagnostics?
Amritaa Diagnostics has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amritaa Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amritaa Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
